{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T11:50:15Z","timestamp":1791805815771,"version":"4.3.4"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["brachyjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brachytherapy"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.brachy.2026.08.001","type":"journal-article","created":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T11:36:40Z","timestamp":1791805000000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Core competencies for plaque brachytherapy in the treatment of uveal melanomas"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8032-4499","authenticated-orcid":false,"given":"Diandra N.","family":"Ayala-Peacock","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9508-4897","authenticated-orcid":false,"given":"Sheridan","family":"Meltsner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1325-1274","authenticated-orcid":false,"given":"Arpita","family":"Maniar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Materin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3633-9685","authenticated-orcid":false,"given":"Junzo","family":"Chino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.brachy.2026.08.001_bib0001","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1002\/cncr.20866","article-title":"Incidence of noncutaneous melanomas in the U.S","volume":"103","author":"McLaughlin","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.brachy.2026.08.001_bib0002","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1159\/000480640","article-title":"Uveal melanoma: 5-year update on incidence, treatment, and survival (SEER 1973-2013)","volume":"4","author":"Aronow","year":"2018","journal-title":"Ocul Oncol Pathol"},{"key":"10.1016\/j.brachy.2026.08.001_bib0003","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.2147\/OPTH.S113623","article-title":"Trends in incidence, survival, and management of uveal melanoma: a population-based study of 7516 patients from the surveillance, epidemiology, and end results database (1973-2012)","volume":"10","author":"Mahendraraj","year":"2016","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.brachy.2026.08.001_bib0004","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/j.ophtha.2011.01.040","article-title":"Uveal melanoma: trends in incidence, treatment, and survival","volume":"118","author":"Singh","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.brachy.2026.08.001_bib0005","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/eye.2016.275","article-title":"Uveal melanoma: relatively rare but deadly cancer","volume":"31","author":"Kaliki","year":"2017","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.brachy.2026.08.001_bib0006","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1001\/archophthalmol.2009.208","article-title":"Metastasis of uveal melanoma millimeter-by-millimeter in 8033 consecutive eyes","volume":"127","author":"Shields","year":"2009","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.brachy.2026.08.001_bib0007","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/S0161-6420(95)30864-0","article-title":"Risk factors for growth and metastasis of small choroidal melanocytic lesions","volume":"102","author":"Shields","year":"1995","journal-title":"Ophthalmology"},{"key":"10.1016\/j.brachy.2026.08.001_bib0008","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1001\/archopht.119.5.670","article-title":"Assessment of metastatic disease status at death in 435 patients with large choroidal melanoma in the collaborative ocular melanomastudy (COMS): COMS report no. 15","volume":"119","year":"2001","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.brachy.2026.08.001_bib0009","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.1200\/JCO.24.00447","article-title":"15-gene expression profile and prame as integrated prognostic test for uveal melanoma: first report of collaborative ocular oncology group study no. 2 (COOG 2.1)","volume":"42","author":"Harbour","year":"2024","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.brachy.2026.08.001_bib0010","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1136\/bjo.14.4.145","article-title":"Choroidal sarcoma treated by the intraocular insertion of radon seeds","volume":"14","author":"Moore","year":"1930","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.brachy.2026.08.001_bib0011","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S0002-9394(98)00039-7","article-title":"The collaborative ocular melanoma study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma ii: initial mortality findings. COMS report no. 10","volume":"125","year":"1998","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.brachy.2026.08.001_bib0012","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1001\/archopht.124.12.1684","article-title":"The coms randomized trial of iodine 125 brachytherapy for choroidal melanoma: V. Twelve-year mortality rates and prognostic factors: COMS report no. 28","volume":"124","year":"2006","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.brachy.2026.08.001_bib0013","doi-asserted-by":"crossref","first-page":"358","DOI":"10.5114\/jcb.2021.106191","article-title":"Efficacy and complications of ruthenium-106 brachytherapy for uveal melanoma: a systematic review and meta-analysis","volume":"13","author":"Karimi","year":"2021","journal-title":"J Contemp Brachytherapy"},{"key":"10.1016\/j.brachy.2026.08.001_bib0014","doi-asserted-by":"crossref","first-page":"6161","DOI":"10.1118\/1.4749933","article-title":"Dosimetry of (125)I and (103)Pd coms eye plaques for intraocular tumors: report of task group 129 by the AAPM and ABS","volume":"39","author":"Chiu-Tsao","year":"2012","journal-title":"Med Phys"},{"key":"10.1016\/j.brachy.2026.08.001_bib0015","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1118\/1.3523614","article-title":"Comparison of dose calculation methods for brachytherapy of intraocular tumors","volume":"38","author":"Rivard","year":"2011","journal-title":"Med Phys"},{"key":"10.1016\/j.brachy.2026.08.001_bib0016","first-page":"1","article-title":"The american brachytherapy society consensus guidelines for plaque brachytherapy of uveal melanoma and retinoblastoma","volume":"13","year":"2014","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2026.08.001_bib0017","doi-asserted-by":"crossref","DOI":"10.1002\/mp.13996","article-title":"Aapm recommendations on medical physics practices for ocular plaque brachytherapy: report of task group 221","volume":"47","author":"Thomson","year":"2020","journal-title":"Med Phys"},{"key":"10.1016\/j.brachy.2026.08.001_bib0018","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.brachy.2025.05.006","article-title":"Joint abs\/gec-estro consensus statement on the objectives of training in brachytherapy for physicians","volume":"24","author":"Keyes","year":"2025","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2026.08.001_bib0019","doi-asserted-by":"crossref","first-page":"i","DOI":"10.1118\/1.4826194","article-title":"Comprehensive brachytherapy: physical and clinical aspects","volume":"40","author":"Thomadsen","year":"2013","journal-title":"Med Phys"},{"key":"10.1016\/j.brachy.2026.08.001_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2024.100513","article-title":"High-dose-rate yttrium-90 ((90)y) episcleral plaque brachytherapy for iris and iridociliary melanoma","volume":"4","author":"Finger","year":"2024","journal-title":"Ophthalmol Sci"},{"key":"10.1016\/j.brachy.2026.08.001_bib0021","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1038\/eye.2015.109","article-title":"Outcomes of treatment with stereotactic radiosurgery or proton beam therapy for choroidal melanoma","volume":"29","author":"Sikuade","year":"2015","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.brachy.2026.08.001_bib0022","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.21873\/anticanres.15674","article-title":"Photon-based high-dose single-fraction radiosurgery, an effective treatment modality for large and posterior uveal melanoma","volume":"42","author":"Laliscia","year":"2022","journal-title":"Anticancer Res"},{"key":"10.1016\/j.brachy.2026.08.001_bib0023","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/CMR.0000000000000364","article-title":"Clinical experience of stereotactic radiosurgery at a linear accelerator for intraocular melanoma","volume":"27","author":"Furdova","year":"2017","journal-title":"Melanoma Res"},{"key":"10.1016\/j.brachy.2026.08.001_bib0024","first-page":"28","article-title":"Stereotactic radiosurgery in intraocular malignant melanoma: retrospective study","volume":"35","author":"Furdova","year":"2014","journal-title":"Neuro Endocrinol Lett"},{"key":"10.1016\/j.brachy.2026.08.001_bib0025","doi-asserted-by":"crossref","DOI":"10.1002\/acm2.13902","article-title":"Transitioning from a coms-based plaque brachytherapy program to using eye physics plaques and plaque simulator treatment planning system: a single institutional experience","volume":"24","author":"Meltsner","year":"2023","journal-title":"J Appl Clin Med Phys"},{"key":"10.1016\/j.brachy.2026.08.001_bib0026","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cancers14133147","article-title":"Imaging of uveal melanoma-current standard and methods in development","volume":"14","author":"Solnik","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.brachy.2026.08.001_bib0027","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S0161-6420(00)00526-1","article-title":"Collaborative ocular melanoma study (COMS) randomized trial of I-125 brachytherapy for medium choroidal melanoma. I. Visual acuity after 3 years COMS report no. 16","volume":"108","author":"Melia","year":"2001","journal-title":"Ophthalmology"},{"key":"10.1016\/j.brachy.2026.08.001_bib0028","doi-asserted-by":"crossref","first-page":"350","DOI":"10.5114\/jcb.2023.132658","article-title":"A study comparing baseline and best-corrected visual acuity after iodine-125 episcleral brachytherapy in uveal melanoma","volume":"15","author":"Miguel","year":"2023","journal-title":"J Contemp Brachytherapy"},{"key":"10.1016\/j.brachy.2026.08.001_bib0029","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cancers16193386","article-title":"Plaque radiotherapy for ocular melanoma","volume":"16","author":"Thomas","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.brachy.2026.08.001_bib0030","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1159\/000504312","article-title":"Practice patterns for the treatment of uveal melanoma with iodine-125 plaque brachytherapy: Ocular Oncology Study Consortium Report 5","volume":"6","author":"Binder","year":"2020","journal-title":"Ocul Oncol Pathol"},{"key":"10.1016\/j.brachy.2026.08.001_bib0031","article-title":"Preliminary results of uveal melanoma treated with iodine-125 plaques: analysis of disease control and visual outcomes with 63 Gy to the target volume","volume":"7","author":"Kheir","year":"2022","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.brachy.2026.08.001_bib0032","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.ijrobp.2009.08.059","article-title":"Alternative dose for choroidal melanoma treated with an iodine-125 radioactive plaque: a single-institution retrospective study","volume":"78","author":"Saconn","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2026.08.001_bib0033","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ajo.2017.11.008","article-title":"Efficacy and safety of low-dose iodine plaque brachytherapy for juxtapapillary choroidal melanoma","volume":"186","author":"Oellers","year":"2018","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.brachy.2026.08.001_bib0034","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1002\/(SICI)1097-0142(19960601)77:11<2356::AID-CNCR26>3.0.CO;2-V","article-title":"125i plaque therapy for uveal melanoma. Analysis of the impact of time and dose factors on local control","volume":"77","author":"Quivey","year":"1996","journal-title":"Cancer"},{"key":"10.1016\/j.brachy.2026.08.001_bib0035","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S0161-6420(94)31338-8","article-title":"Palladium 103 plaque radiotherapy for uveal melanoma. Clinical experience","volume":"101","author":"Finger","year":"1994","journal-title":"Ophthalmology"},{"key":"10.1016\/j.brachy.2026.08.001_bib0036","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1118\/1.1646040","article-title":"Update of AAPM task group no. 43 report: a revised AAPM protocol for brachytherapy dose calculations","volume":"31","author":"Rivard","year":"2004","journal-title":"Med Phys"},{"key":"10.1016\/j.brachy.2026.08.001_bib0037","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/S0161-6420(02)01277-0","article-title":"The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: iv. Local treatment failure and enucleation in the first 5 years after brachytherapy. COMS report no. 19","volume":"109","author":"Jampol","year":"2002","journal-title":"Ophthalmology"},{"key":"10.1016\/j.brachy.2026.08.001_bib0038","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1159\/000455872","article-title":"Iodine-125 brachytherapy for uveal melanoma: a systematic review of radiation dose","volume":"3","author":"Echegaray","year":"2017","journal-title":"Ocul Oncol Pathol"},{"key":"10.1016\/j.brachy.2026.08.001_bib0039","doi-asserted-by":"crossref","first-page":"392","DOI":"10.5114\/jcb.2019.87407","article-title":"Complications and adverse events of plaque brachytherapy for ocular melanoma","volume":"11","author":"Peddada","year":"2019","journal-title":"J Contemp Brachyther"},{"key":"10.1016\/j.brachy.2026.08.001_bib0040","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0002-9394(98)00445-0","article-title":"Radiation complications and tumor control after plaque radiotherapy of choroidal melanoma with macular involvement","volume":"127","author":"Gunduz","year":"1999","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.brachy.2026.08.001_bib0041","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1136\/bjo.84.9.1068","article-title":"Tumour location affects the incidence of cataract and retinopathy after ophthalmic plaque radiation therapy","volume":"84","author":"Finger","year":"2000","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.brachy.2026.08.001_bib0042","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.radonc.2021.11.007","article-title":"Local tumor control and treatment related toxicity after plaque brachytherapy for uveal melanoma: a systematic review and a data pooled analysis","volume":"166","author":"Buonanno","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2026.08.001_bib0043","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1016\/S0161-6420(02)01181-8","article-title":"Plaque radiotherapy for large posterior uveal melanomas (>or =8-mm thick) in 354 consecutive patients","volume":"109","author":"Shields","year":"2002","journal-title":"Ophthalmology"},{"key":"10.1016\/j.brachy.2026.08.001_bib0044","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0161-6420(87)33456-6","article-title":"Long-term results of proton beam irradiated uveal melanomas","volume":"94","author":"Gragoudas","year":"1987","journal-title":"Ophthalmology"},{"key":"10.1016\/j.brachy.2026.08.001_bib0045","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0161-6420(89)32806-5","article-title":"Reasons for enucleation after plaque radiotherapy for posterior uveal melanoma. Clinical findings","volume":"96","author":"Shields","year":"1989","journal-title":"Ophthalmology"},{"key":"10.1016\/j.brachy.2026.08.001_bib0046","doi-asserted-by":"crossref","first-page":"3797","DOI":"10.2147\/OPTH.S219268","article-title":"Radiation retinopathy: detection and management strategies","volume":"15","author":"Sahoo","year":"2021","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.brachy.2026.08.001_bib0047","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3109\/0284186X.2010.500299","article-title":"Current treatments for radiation retinopathy","volume":"50","author":"Giuliari","year":"2011","journal-title":"Acta Oncol"},{"key":"10.1016\/j.brachy.2026.08.001_bib0048","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.oret.2019.02.009","article-title":"Aflibercept for radiation maculopathy study: a prospective, randomized clinical study","volume":"3","author":"Murray","year":"2019","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.brachy.2026.08.001_bib0049","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/IIO.0b013e31821e5960","article-title":"Medical and surgical treatment of neovascular glaucoma","volume":"51","author":"Olmos","year":"2011","journal-title":"Int Ophthalmol Clin"},{"key":"10.1016\/j.brachy.2026.08.001_bib0050","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3928\/23258160-20150213-08","article-title":"Anti-vegf intravitreal bevacizumab for radiation-associated neovascular glaucoma","volume":"46","author":"Nagendran","year":"2015","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"10.1016\/j.brachy.2026.08.001_bib0051","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/IJG.0b013e31825c0fb7","article-title":"Red laser cyclophotocoagulation in the treatment of secondary glaucoma in eyes with uveal melanoma","volume":"23","author":"Piirtola","year":"2014","journal-title":"J Glaucoma"}],"container-title":["Brachytherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472126002837?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472126002837?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T11:36:47Z","timestamp":1791805007000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538472126002837"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":51,"alternative-id":["S1538472126002837"],"URL":"https:\/\/doi.org\/10.1016\/j.brachy.2026.08.001","relation":{},"ISSN":["1538-4721"],"issn-type":[{"value":"1538-4721","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Core competencies for plaque brachytherapy in the treatment of uveal melanomas","name":"articletitle","label":"Article Title"},{"value":"Brachytherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brachy.2026.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Brachytherapy Society. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}